Polaris Venture Management Co. V, L.L.C.

Holdings History for FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Symbol: FATE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2021		-79%	$0	0	-569,889	-100%	$1.09	Q3 2021
30 Jun 2021	79%	0%	$49,461,000	569,889	0		$86.79	Q2 2021
31 Mar 2021	61%	0%	$46,987,000	569,889	0		$82.45	Q1 2021
31 Dec 2020	68%	-34%	$51,820,000	569,889	-284,947	-33%	$90.93	Q4 2020
30 Sep 2020	56%	-19%	$34,168,000	854,836	-284,947	-25%	$39.97	Q3 2020
30 Jun 2020	30%	0%	$39,106,000	1,139,783	0		$34.31	Q2 2020
31 Mar 2020	23%	0%	$25,315,000	1,139,783	0		$22.21	Q1 2020
31 Dec 2019	16%	0%	$22,306,000	1,139,783	0		$19.57	Q4 2019
30 Sep 2019	10%	-2.9%	$17,701,000	1,139,783	-333,403	-23%	$15.53	Q3 2019
30 Jun 2019	23%	0%	$29,906,000	1,473,186	0		$20.30	Q2 2019
31 Mar 2019	22%	-5.2%	$25,884,000	1,473,186	-350,000	-19%	$17.57	Q1 2019
31 Dec 2018	25%	-8.9%	$23,391,000	1,823,186	-650,000	-26%	$12.83	Q4 2018
30 Sep 2018	20%	0%	$40,288,000	2,473,186	0		$16.29	Q3 2018
30 Jun 2018	15%	0%	$28,046,000	2,473,186	0		$11.34	Q2 2018
31 Mar 2018	14%	0%	$24,138,000	2,473,186	0		$9.76	Q1 2018
31 Dec 2017	13%	0%	$15,111,000	2,473,186	0		$6.11	Q4 2017
30 Sep 2017	8.4%	0%	$9,794,000	2,473,186	0		$3.96	Q3 2017
30 Jun 2017	9.8%	0%	$8,013,000	2,473,186	0		$3.24	Q2 2017
31 Mar 2017	12%	0%	$11,253,000	2,473,186	0		$4.55	Q1 2017
31 Dec 2016	7.4%	0%	$6,208,000	2,473,186	0		$2.51	Q4 2016
30 Sep 2016	8.1%	0%	$7,716,000	2,473,186	0		$3.12	Q3 2016
30 Jun 2016	4.5%	0%	$4,204,000	2,473,186	0		$1.70	Q2 2016
31 Mar 2016	4.3%	0%	$4,452,000	2,473,186	0		$1.80	Q1 2016
31 Dec 2015	6.5%	0%	$8,335,000	2,473,186	0		$3.37	Q4 2015
30 Sep 2015	9%	0%	$13,182,000	2,473,186	0		$5.33	Q3 2015
30 Jun 2015	7.1%	0%	$16,002,000	2,473,186	0		$6.47	Q2 2015
31 Mar 2015	5.4%	0%	$12,094,000	2,473,186	0		$4.89	Q1 2015
31 Dec 2014	9.8%	0%	$12,440,000	2,473,186	0		$5.03	Q4 2014
30 Sep 2014	9.7%	0%	$12,613,000	2,473,186	0		$5.10	Q3 2014
30 Jun 2014	13%	0%	$15,606,000	2,473,186	0		$6.31	Q2 2014
31 Mar 2014	20%	0%	$24,089,000	2,473,186	0		$9.74	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.